HomeTagsCANbridge

CANbridge

Healthcare

CANbridge Pharmaceuticals CAN108 New Drug Application (NDA) for Alagille Syndrome Accepted by China’s National Medical Products Administration

Business Wire - January 19, 2022

CANbridge Pharmaceuticals Inc., (“CANbridge,” stock code 1228.HK) a leading China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease...

Hot Topics

Keysight Unveils HDMI Physical Layer Compliance Test Solution

Peraton and Okta Collaborate with U.S. DoD to Advance myAuth

Vontier’s Driivz Team Up With ENAPI for EV Roaming Connectivity